Dr. Thomas Gillespie Smith III, MD

Dr. Smith practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Smith's NPI, 1407864036, was assigned on August 3, 2006. Dr. Smith graduated from UTMB Health in 1997. Dr. Smith's Texas license number on file is L5565.

Dr. Smith's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Smith's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service. Dmand AI also links Dr. Smith to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices. Vendor and product names are available with a free account.

Urology is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Smith is board certified in urology by the American Board of Urology. Dmand AI has Dr. Smith's licenses on file in 10 states: Texas, Florida, Arizona, Georgia, Tennessee, Louisiana, Mississippi, Oklahoma, Washington and Alabama.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, prostate cancer and urinary endoscopy among the conditions Dr. Smith treats.

CMS data shows 238 Medicare services from Dr. Smith across 8 procedure codes in 2024, for 170 Medicare patients. Medicare paid $14,734 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 170 Medicare patients who saw Dr. Smith in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 73, with 24% women.

In 2024, Dr. Smith wrote 221 Medicare Part D claims for 101 patients. 89% of them were for generic drugs. CMS names the drug for 138 of them, across 7 drugs with 11 or more claims each, at $18,644 in total drug cost. In 2023, CMS named 82 claims across 4 drugs.

Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smith as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Smith, published from 2010 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Urethra, Urethral Stricture and Urologic Surgical Procedures, Male. Dr. Smith has published most often in Urology. Dr. Smith's most frequent co-authors are Bradley A. Erickson, MD, Benjamin Newell Breyer, MD and Joshua Alan Broghammer, MD.

CMS Open Payments shows 60 general payments to Dr. Smith from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Boston Scientific Corporation paid the most, $10,743.

Dmand AI lists 2 awards for Dr. Smith, most recently CMS Stage 1 EHR in 2013.

Dr. Smith graduated from UTMB Health in 1997. Dr. Smith is a member of ACS.

Dr. Smith is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.